This event has an open abstract session. Abstracts can be submitted on any
subject related to Malaria
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at
www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
EVENT DETAILs
29th June 2015 – 1st July 2015
LONDON, UK
With plenty of opportunity for networking and debate, this informal, multi-disciplinary international meeting will bring you up to date with current research and thinking regarding Malaria infection, treatment and eradication.
Talks include:
- Antimalarial drug discovery and validation of new targets: Professor Edward Tate, Department of Chemistry, Imperial College London, UK
- Immunoprofiling of vaccinees: Dr. Elke Bergmann-Leitner, Chief, Flow Cytometry Center, MVDB/USMMRP/WRAIR, Silver Spring, MD, USA
- Symbiotic control of malaria vectors: Associate Professor Guido Favia, School of Biosciences & Veterinary Medicine, University of Camerino, Camerino, Italy
- How genomics is contributing to the fight against artemisinin-resistant malaria: Dr Pedro Cravo, Universidade Federal de Goiás, Goiânia, Brazil
- Systematic analysis of malaria-related research investments awarded to UK institutions 1997-2013: where’s the money gone Dr Michael head,Network Manager, Infectious Disease Research Network, Based at the UCL Farr Institute, London, United Kingdom
- Computational modelling of the interactions between antimalarial drugs and hemozoin crystal faces: Dr Marcus C. Durrant, Northumbria University, London, UK
- Development and evaluation of a direct on blood PCR-NALFIA system (DIAGMAL): bringing molecular diagnostics to the field: Dr Henk Schallig, Royal Tropical Institute / Koninklijk Institut voor de Tropen – Parasitology Unit, The Netherlands
- Role of hemozoin in the pathogenesis of malaria-associated acute respiratory distress syndrome: Professor Philippe Van den Steen, Laboratory of Immunobiology, Rega Institute for Medical Reseach, University of Leuven – KU Leuven, Belgium
- Polyamidoamine nanoparticles: A versatile dual tool for malaria therapeutics and prophylaxis: Dr Xavier Fernàndez Busquets, Research Associate, Institute for Bioengineering of Catalonia, Barcelona, Spain
- Visiting Friends and Relatives (VFRs) travelers and imported malaria: Professor Paola Di Carlo, Department of Sciences for Health Promotion and Mother-Child Care, University of Palermo, Italy.
- Plasmodium infection of Anopheles species from the Amazon: Development of experimental models of neglected vectors when compared to other malaria vectors: Dr. Paulo F. P. Pimenta, Laboratory of Medical Entomology, Head Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz – FIOCRUZ, Brazil
- TBC: Dr Elinor Hortle, Macquarie University, Australian School of Advanced Medicine, Australia
- Regulators of Plamsodium falciparum Protein Phosphatases: new means to control malaria: Dr Jamal Khalife, Univ Lille Nord de France, Lille Cedex, France
- Towards next generation of medicines to meet the ambitious goal of malaria eradication: Dr Benjamin Blasco, Medicines for Malaria Venture, Switzerland
- Beating Malaria: A ten-year retrospective report from Nigeria: Mr Emmanuel Chike Amadi, Department of Medical Microbiology, College of Medicine, Enugu State University of Science and Technology, Nigeria.
- TBC: Dr Wilfred F. Mbacham, University of Yaounde, Yaounde, Cameroon
- TBC: Dr Harparkash Kaur, LSHTM, London, United Kingdom
- Malaria, cognition and education: what can we learn : Dr Sian E. Clarke, London School of Hygiene & Tropical Medicine, University of London, London, United Kingdom
4-aminoquinolone adjuvant Amodiaquine Anopheles Anopheles vectors antibody antibody responses Antimalarial Antimalarial drug discovery antimalarial efficacy antiplasmodial Artemisinin Artemisinin resistance Aspirin Atovaquone B cells Biological Control Burden cerebral malaria chemical biology chemical control Chloroquine Citrulline Clindamycin. combination combination therapies continuous Control correlates of protection cryptolepine dihydroartemisinin Doxycycline drug development; molecular modelling; quantum calculations Education elimination Environmental change financing Fundin Genomics Habitat Control Halofantrine hemozoin Immigrants Immune response immunology immunoprofiling Immunotherapy imported malaria Incidence inflammation Insecticide Investments LLIN local anaesthetic maintenance malaria malaria prophylaxis malaria therapeutics medicines Mefloquine Mefloquine derivatives molecular diagnostics Molecular markers N-myristoyltransferase nanomedicine Nigeria Nitric Oxide NK65 novel analgesic novel mode of action pain assessment Pain management conference pain science Palestine Parasitostatic Phosphatases placenta Plasmodial control plasmodium Plasmodium berghei Plasmodium falciparum Plasmodium species platelets policy poly(amidoamine) Polyphenols Pregnancy Primaquine Proguanil prophylaxis pseudotype pulmonary complications pyrethroid Pyrimethamine Quinine regulators repellent reseach research Resistance Salinity tolerance Sea level rise Severe malaria stereochemistry Surveillance T cells targeted drug delivery therapy traditional antimalarial plants Travelers tsetse flies vaccination conference vaccine delivery systems vaccine efficacy vaccine saftey vaccine summit VaccineVaccine delivery Vector visiting friends and relatives (VFRs)
